Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gremmel

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
The New England Journal of Medicine|February 19, 2025
Edoxaban for Atrial Fibrillation and Stable Coronary Artery DiseaseThomas Gremmel
The New England Journal of Medicine|November 18, 2020
Rivaroxaban in Peripheral Artery Disease after RevascularizationThomas Gremmel
Wiener Klinische Wochenschrift|June 19, 2010
[Researcher of the month]Thomas Gremmel
The New England Journal of Medicine|December 19, 2019
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary DiseaseThomas Gremmel
Seminars in Thrombosis and Hemostasis|December 1, 2022
Antiplatelet Therapy in Coronary Artery Disease: Now and ThenMaximilian Tscharre, Thomas Gremmel
Lancet (London, England)|March 16, 2020
Antithrombotic treatment strategies after PCIThomas Gremmel, Kurt Huber
Thrombosis and Haemostasis|May 27, 2011
Clinical, genetic and confounding factors determine the dynamics of the in vitro response/non response to clopidogrelThomas Gremmel, Simon Panzer
Plos One|June 10, 2015
Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet TherapyThomas Gremmel, Renate Koppensteiner, Simon Panzer
JACC. Case Reports|January 29, 2026
Successful Takeuchi Repair in a 48-Year-Old Woman With ALCAPALukas Resemann, Thomas Gremmel, Dominik Wiedemann
European Heart Journal. Cardiovascular Pharmacotherapy|July 3, 2019
Critical appraisal of the AUGUSTUS trialThomas Gremmel, Patrick Sulzgruber, Alexander Niessner
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|February 19, 2025
Edoxaban for Atrial Fibrillation and Stable Coronary Artery DiseaseThomas Gremmel
The New England Journal of Medicine|November 18, 2020
Rivaroxaban in Peripheral Artery Disease after RevascularizationThomas Gremmel
Wiener Klinische Wochenschrift|June 19, 2010
[Researcher of the month]Thomas Gremmel
The New England Journal of Medicine|December 19, 2019
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary DiseaseThomas Gremmel
Seminars in Thrombosis and Hemostasis|December 1, 2022
Antiplatelet Therapy in Coronary Artery Disease: Now and ThenMaximilian Tscharre, Thomas Gremmel
Lancet (London, England)|March 16, 2020
Antithrombotic treatment strategies after PCIThomas Gremmel, Kurt Huber
Thrombosis and Haemostasis|May 27, 2011
Clinical, genetic and confounding factors determine the dynamics of the in vitro response/non response to clopidogrelThomas Gremmel, Simon Panzer
Plos One|June 10, 2015
Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet TherapyThomas Gremmel, Renate Koppensteiner, Simon Panzer
JACC. Case Reports|January 29, 2026
Successful Takeuchi Repair in a 48-Year-Old Woman With ALCAPALukas Resemann, Thomas Gremmel, Dominik Wiedemann
European Heart Journal. Cardiovascular Pharmacotherapy|July 3, 2019
Critical appraisal of the AUGUSTUS trialThomas Gremmel, Patrick Sulzgruber, Alexander Niessner
Pageof 14